Patents by Inventor Andrew D. Reddick

Andrew D. Reddick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130005823
    Abstract: This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended to deter abuse of the active drug substance via injection, nasal inhalation or consumption of quantities of the dosage unit exceeding the usual therapeutically effective dose.
    Type: Application
    Filed: August 31, 2012
    Publication date: January 3, 2013
    Applicant: ACURA PHARMACEUTICALS, INC.
    Inventors: James F. EMIGH, Ronald L. LEECH, JR., Andrew D. REDDICK, Ron J. SPIVEY
  • Publication number: 20120202839
    Abstract: This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended to deter abuse of the active drug substance via injection, nasal inhalation or consumption of quantities of the dosage unit exceeding the usual therapeutically effective dose.
    Type: Application
    Filed: April 18, 2012
    Publication date: August 9, 2012
    Applicant: ACURA PHARMACEUTICALS, INC.
    Inventors: James F. EMIGH, Ronald L. LEECH, JR., Andrew D. REDDICK, Ron J. SPIVEY
  • Publication number: 20080152595
    Abstract: This invention relates to an abuse deterrent formulation of an oral dosage form of a therapeutically effective amount of any active drug substance that can be subject to abuse combined with a gel forming polymer, a nasal mucosal irritating surfactant and a flushing agent. Such a dosage form is intended to deter abuse of the active drug substance via injection, nasal inhalation or consumption of quantities of the dosage unit exceeding the usual therapeutically effective dose.
    Type: Application
    Filed: December 12, 2007
    Publication date: June 26, 2008
    Inventors: James F. Emigh, Ronald L. Leech, Andrew D. Reddick, Ron J. Spivey